Leadership Overview
B. Braun has 10 executives leading key functions including financial strategy, administrative oversight, operational management, and regional leadership.
Committed to advancing global healthcare standards, B. Braun delivers innovative medical products and pharmaceutical solutions to improve patient outcomes across international markets.
Committed to advancing global healthcare standards, B. Braun delivers innovative medical products and pharmaceutical solutions to improve patient outcomes across international markets.
Leadership Roles at B. Braun
Sri Sulistiowati - Chief Financial Officer
Sri Sulistiowati, the Chief Financial Officer at B. Braun, directs the global fiscal strategy and capital allocation processes. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the development of medical devices and pharmaceutical products. This leadership role involves managing complex budgetary frameworks across diverse international markets to maintain long-term profitability. By optimizing resource distribution, Sri Sulistiowati directly impacts the ability of the company to invest in research and development for infusion therapy and surgical instruments. Sulistiowati maintains close collaboration with the board to align fiscal objectives with the broader mission of enhancing patient care. Through disciplined financial oversight, the Chief Financial Officer secures the necessary capital to sustain the expansive manufacturing footprint of the organization in over 60 countries worldwide.
Thomas Whalen - Interim Chief Financial Officer (North America)
Thomas Whalen, the Interim Chief Financial Officer (North America) at B. Braun, manages the regional financial operations and fiscal reporting requirements within the North American market. Overseeing the integration of financial data across regional manufacturing and distribution channels, the Interim Chief Financial Officer (North America) ensures that local business units remain aligned with the overarching corporate strategy. This role involves mitigating regional economic risks and driving cost-efficiency initiatives to support the delivery of hospital pharmacy solutions and wound care products. Thomas Whalen coordinates with executive leadership to refine regional investment strategies and improve operational margins. By analyzing market trends and regional performance metrics, Whalen strengthens the competitive position of the company within the North American healthcare sector. The Interim Chief Financial Officer (North America) provides critical financial insights that enable the organization to scale its medical product offerings effectively across the continent.
Scott Farrell - Group Chief Financial Officer
Scott Farrell, the Group Chief Financial Officer at B. Braun, architects the consolidated financial architecture and global investment strategy for the entire multinational enterprise. Overseeing the financial performance of all business segments, the Group Chief Financial Officer ensures that capital investments support the manufacturing of high-quality medical devices and pharmaceutical solutions. This leadership role involves managing global liquidity, tax planning, and investor relations to maintain the financial stability of the organization. Scott Farrell drives the implementation of advanced financial reporting systems that provide transparency across the global operations of the company. By aligning group-wide fiscal policies with the long-term growth objectives of the firm, Farrell facilitates the expansion of dialysis and infusion therapy services. The Group Chief Financial Officer maintains a focus on sustainable value creation, ensuring that the financial foundation remains robust enough to support continuous innovation in medical technology.
Cristian Vacarezza - Principal Chief Financial Officer
Cristian Vacarezza, the Principal Chief Financial Officer at B. Braun, leads the strategic financial planning and risk management initiatives for the core business divisions. Overseeing the financial modeling for new product launches, the Principal Chief Financial Officer ensures that the development of surgical instruments and medical devices remains economically viable. This role involves collaborating with cross-functional teams to optimize the supply chain and manufacturing costs. Cristian Vacarezza monitors global market fluctuations to protect the financial interests of the company while fostering growth in key therapeutic areas. By implementing rigorous financial controls, Vacarezza supports the delivery of high-quality healthcare solutions to hospitals and clinics worldwide. The Principal Chief Financial Officer provides the analytical rigor necessary to evaluate potential acquisitions and partnerships that align with the strategic vision of the organization. Through this leadership, the company maintains a strong balance sheet and consistent operational performance.
Muhammad Arqam - Chief Financial Officer & Head of Strategic Accounts Management
Muhammad Arqam, the Chief Financial Officer & Head of Strategic Accounts Management at B. Braun, integrates financial oversight with the management of high-value client relationships. Overseeing the profitability of strategic accounts, the Chief Financial Officer & Head of Strategic Accounts Management ensures that the delivery of medical products and services meets the specific needs of large-scale healthcare providers. This role involves negotiating complex contracts and aligning financial terms with the long-term service requirements of major hospital networks. Muhammad Arqam drives the development of customized financial solutions that enhance the value proposition of the company in the medical device market. By balancing account growth with fiscal discipline, Arqam strengthens the market presence of the organization. The Chief Financial Officer & Head of Strategic Accounts Management coordinates with sales and operations teams to ensure that strategic accounts receive consistent support, thereby securing recurring revenue streams and fostering deep industry partnerships.
Yazmin Ruiz - Chief Financial Officer (Mexico)
Yazmin Ruiz, the Chief Financial Officer (Mexico) at B. Braun, manages the financial operations and regulatory compliance for the Mexican market. Overseeing the local fiscal strategy, the Chief Financial Officer (Mexico) ensures that the manufacturing and distribution of medical products align with regional economic conditions and local healthcare regulations. This role involves managing local cash flow, tax obligations, and financial reporting to support the expansion of the company in the region. Yazmin Ruiz coordinates with the global finance team to ensure that regional performance metrics contribute effectively to the overall success of the organization. By optimizing local operational costs and improving financial efficiency, Ruiz supports the delivery of essential medical devices and pharmaceutical solutions to the Mexican healthcare sector. The Chief Financial Officer (Mexico) provides the necessary financial leadership to navigate the complexities of the regional market while maintaining the high standards of the company.
Punrada Lertkomonsuk - Chief Financial Officer, B Braun Ltd (Thailand)
Punrada Lertkomonsuk, the Chief Financial Officer, B Braun Ltd (Thailand) at B. Braun, directs the financial management and administrative functions for the Thai subsidiary. Overseeing the local financial planning and analysis, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that the company maintains a competitive edge in the regional medical device market. This role involves managing local regulatory reporting, currency risk, and operational budgets to support the distribution of infusion therapy and wound care products. Punrada Lertkomonsuk collaborates with regional leadership to implement strategies that drive growth and operational efficiency within the Thai market. By ensuring financial transparency and compliance, Lertkomonsuk supports the mission of the company to provide high-quality healthcare solutions to local patients. The Chief Financial Officer, B Braun Ltd (Thailand) plays a vital role in aligning the local business unit with the global strategic objectives of the organization.
Kikoo Tejwani - President
Kikoo Tejwani, the President at B. Braun, directs the overall strategic vision and business development initiatives for the organization. Overseeing the execution of the corporate mission, the President ensures that the company continues to lead in the development and marketing of medical products and pharmaceutical solutions. This leadership role involves setting the long-term direction for the firm, fostering innovation in areas such as wound care and hospital pharmacy solutions, and maintaining strong relationships with global stakeholders. Kikoo Tejwani coordinates with the executive team to drive growth and ensure that the company remains at the forefront of the medical device industry. By championing a culture of excellence and patient-centered care, Tejwani guides the organization through complex market challenges. The President provides the strategic leadership necessary to expand the global footprint of the company while maintaining the high standards of quality and reliability that define the brand.
Paul Alderete - Chief Administrative Officer
Paul Alderete, the Chief Administrative Officer at B. Braun, directs the internal administrative infrastructure and organizational support systems. Overseeing the operational efficiency of corporate functions, the Chief Administrative Officer ensures that the company maintains a seamless workflow across its global manufacturing and pharmaceutical divisions. This role involves managing internal processes, facility operations, and administrative policies that support the workforce in delivering high-quality medical products. Paul Alderete collaborates with other C-suite leaders to streamline organizational communication and improve the overall effectiveness of the business. By optimizing administrative workflows, Alderete enables the company to focus on its core mission of advancing medical technology and patient care. The Chief Administrative Officer provides the structural foundation necessary for the organization to operate effectively in over 60 countries, ensuring that all administrative activities remain aligned with the long-term strategic goals of the firm.
Mor Vamos - Chief Operations Officer
Mor Vamos, the Chief Operations Officer at B. Braun, directs the global manufacturing and supply chain operations for the entire medical device and pharmaceutical portfolio. Overseeing the production facilities and logistics networks, the Chief Operations Officer ensures that the company delivers high-quality infusion therapy, surgical instruments, and dialysis products to healthcare providers worldwide. This role involves optimizing manufacturing processes to increase efficiency and maintain strict quality control standards across all international sites. Mor Vamos collaborates with the executive team to scale production capabilities in response to global market demand. By driving operational excellence, Vamos supports the ability of the company to innovate and provide reliable medical solutions. The Chief Operations Officer manages the complex interplay between supply chain management and product distribution, ensuring that the organization maintains its position as a leader in the global medical technology industry.
Explore Leadership Teams in Manufacturing
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership VA
SE
CV
LifeNet Health is a nonprofit organization dedicated to advancing the field of regenerative medicine through innovative transplantation and cellular solutions. The organization provides comprehensive tissue and organ donation services while supporting healthcare providers, researchers, and patients worldwide. By combining cutting-edge medical technology with rigorous quality standards, LifeNet Health enables life-saving procedures and regenerative therapies that enhance patient outcomes and improve quality of life.
Company Leadership RT
JS
PG
PJ
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership
Teleflex Incorporated is a global provider of medical technology products founded in 1943 and headquartered in Wayne, Pennsylvania. The company designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex's product portfolio spans vascular access, interventional cardiology and radiology, anesthesia, respiratory care, surgery, and urology, serving healthcare providers across more than 40 countries. The company operates through three geographic segments Americas, EMEA, and Asia Pacific and markets its products under a portfolio of established brands. Teleflex trades on the New York Stock Exchange under the ticker symbol TFX.
Company Leadership
Frequently Asked Questions Regarding B. Braun Top Executives and Leadership Team
